Business Standard

Promoter pledging in Apollo Hospitals may come down to 20-25%, says CFO

The promoter group shareholding in AHEL was around 30.80 per cent at the end of September, 2019, of which around 66.19 per cent is pledged, according to regulatory filing

Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt
Premium

Apollo Hospitals

Gireesh Babu Chennai
The promoter entity’s pledged shares in Apollo Hospitals Enterprise (AHEL) will come down to a manageable level.

It rose above 70 per cent a couple of quarters before, raising concerns in the market. At end-September, the promoter group shareholding was 30.8 per cent, of which about 66 per cent was pledged, according to a regulatory filing “The Apollo Munich transaction (stake sale in it) is expected to fructify over the next one month — a final leg of regulatory clearances is awaited. Once that (happens), we hope to see the promoter pledge also come down to a manageable 20-25 per cent.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in